Clinical Trials Updated in 2024

NCT04188964 | COMPLETED | PHASE1/PHASE2

16 participants

Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2020-02-26
Completion:: 2023-10-04

Conditions

X-linked Hypophosphatemia (XLH)

Interventions

DRUG

No Results Yet

NCT04153786 | TERMINATED | NA

9 participants

Effect of Cardiac Resynchronization Therapy (CRT) on Left Ventricular Assist Device (LVAD) Function

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2019-11-02
Completion:: 2023-11-07

Conditions

LVAD (Left Ventricular Assist Device) Driveline Infection

Interventions

OTHER

No Results Yet

NCT04041375 | COMPLETED | NA

219 participants

Veteran Support and Resources for Diabetes

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2019-10-01
Completion:: 2022-08-09

Conditions

Diabetes

Interventions

BEHAVIORAL
OTHER

Results Available

NCT04012216 | COMPLETED

55 participants

Sleep Respiratory Disorders in Patients With Moderate to Severe Persistent Rhinitis

Study Type:: OBSERVATIONAL
Last Updated:: 2024-11-07
Start Date:: 2020-01-28
Completion:: 2024-06-25

Conditions

Rhinitis

Interventions

DEVICE

No Results Yet

NCT03985046 | COMPLETED | PHASE2

75 participants

Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2019-10-10
Completion:: 2021-05-31

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG

No Results Yet

NCT03979131 | ACTIVE_NOT_RECRUITING | PHASE2

40 participants

Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC)

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2019-08-22
Completion:: 2023-03-15

Conditions

Gastroesophageal Junction Adenocarcinoma
Stomach Neoplasms

Interventions

COMBINATION_PRODUCT

No Results Yet

NCT03900884 | ACTIVE_NOT_RECRUITING | PHASE1

17 participants

Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2019-09-25
Completion:: 2025-06-30

Conditions

Breast Neoplasm Female

Interventions

DRUG

No Results Yet

NCT03874026 | RECRUITING | PHASE2

34 participants

Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2019-09-05
Completion:: 2023-05-19

Conditions

Colorectal Cancer
ADCC

Interventions

DRUG

No Results Yet

NCT03866460 | COMPLETED

30 participants

Determining Whether Intra-Arterial Carboplatin Causes Hearing Loss in Children

Study Type:: OBSERVATIONAL
Last Updated:: 2024-11-07
Start Date:: 2019-03-06
Completion:: 2024-11-04

Conditions

Intraocular Retinoblastoma
Hearing Loss

Interventions

DIAGNOSTIC_TEST

No Results Yet

NCT03833427 | TERMINATED | PHASE1

32 participants

Study of Selumetinib (MK-5618) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (MK-5618-001)

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2019-03-18
Completion:: 2022-06-28

Conditions

Advanced/Metastatic Solid Tumors

Interventions

DRUG

Results Available

NCT03825744 | COMPLETED | PHASE3

240 participants

Hetrombopag or Placebo in Treatment-Naive Severe Aplastic Anemia

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2019-03-05
Completion:: 2024-07-03

Conditions

Severe Aplastic Anemia

Interventions

DRUG

No Results Yet

NCT03710044 | WITHDRAWN | PHASE4

0 participants

Investigation of Flare and Remission in Subjects With Atopic Dermatitis

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2019-01-14
Completion:: 2020-08-31

Conditions

Atopic Dermatitis

Interventions

DRUG

No Results Yet

NCT03704974 | TERMINATED

7 participants

The Impact of Parent Training on the Child's Health Services

Study Type:: OBSERVATIONAL
Last Updated:: 2024-11-07
Start Date:: 2018-08-16
Completion:: 2022-06-22

Conditions

Parenting
Child Rearing
Child Behavior Problem

Interventions

BEHAVIORAL

No Results Yet

NCT03671486 | COMPLETED

100 participants

Colonization with Group B Streptococcus During Pregnancy

Study Type:: OBSERVATIONAL
Last Updated:: 2024-11-07
Start Date:: 2018-12-05
Completion:: 2020-07-13

Conditions

Gestational Mother
Streptococcus Agalactiae Infection

No Results Yet

NCT03670927 | COMPLETED

2237 participants

Etiosarc: Environmental Aetiology of Sarcomas From a Multicenter French Population-based Case-control Study Among Adults

Study Type:: OBSERVATIONAL
Last Updated:: 2024-11-07
Start Date:: 2019-04-25
Completion:: 2024-07-03

Conditions

Sarcoma
Environmental Exposure
Occupational Exposure
Life Style

Interventions

OTHER

No Results Yet

NCT03630042 | COMPLETED | PHASE2

17 participants

Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2019-09-06
Completion:: 2021-09-21

Conditions

Waldenstrom Macroglobulinemia

Interventions

DRUG

Results Available

NCT03615573 | COMPLETED

103 participants

Survey Study: Financial Impact of Breast Cancer Treatment

Study Type:: OBSERVATIONAL
Last Updated:: 2024-11-07
Start Date:: 2018-09-04
Completion:: 2022-06-15

Conditions

Breast Cancer

Interventions

OTHER

No Results Yet

NCT03553927 | COMPLETED | NA

73 participants

Investigating the Physiological Effects of Weight Loss on Male Fertility

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2018-05-16
Completion:: 2023-08-20

Conditions

Male Infertility
Obesity
Weight Loss

Interventions

DIETARY_SUPPLEMENT
OTHER

Results Available

NCT03509285 | COMPLETED | PHASE1

53 participants

A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2017-03-08
Completion:: 2017-11-18

Conditions

Healthy Volunteer

Interventions

DRUG

No Results Yet

NCT03458962 | RECRUITING

1000 participants

Diagnostic Odyssey: Whole Genome Sequencing (WGS)

Study Type:: OBSERVATIONAL
Last Updated:: 2024-11-07
Start Date:: 2018-02-20
Completion:: 2070-03-31

Conditions

Genetic Disease
Genetic Syndrome

Interventions

GENETIC

No Results Yet

NCT03414034 | COMPLETED | PHASE2

72 participants

Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2018-08-14
Completion:: 2023-10-16

Conditions

Metastatic Castration-Resistant Prostate Cancer

Interventions

DRUG

Results Available

NCT03318900 | COMPLETED | PHASE1/PHASE2

5 participants

T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2018-09-04
Completion:: 2023-12-20

Conditions

COL6A3 Positive
HLA-A*0201 Positive Cells Present
PRAME Positive
Recurrent Ovarian Carcinoma

Interventions

BIOLOGICAL
DRUG
PROCEDURE

Results Available

NCT03297541 | COMPLETED | NA

10 participants

Healthy Kids I-PAL

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2017-09-05
Completion:: 2017-12-12

Conditions

Childhood Obesity

Interventions

BEHAVIORAL

Results Available

NCT03227328 | COMPLETED | PHASE2

52 participants

CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2017-08-02
Completion:: 2022-02-01

Conditions

Hormone Receptor Positive Breast Cancer
Metastatic Breast Cancer
Hormone Receptor Negative Breast Cancer

Interventions

DRUG

No Results Yet

NCT02938442 | COMPLETED | PHASE1/PHASE2

16 participants

Vaccination of Triple Negative Breast Cancer Patients

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2019-01-25
Completion:: 2023-01-09

Conditions

Triple Negative Breast Cancer
Breast Neoplasms

Interventions

BIOLOGICAL
DRUG

Results Available

NCT02899312 | ACTIVE_NOT_RECRUITING

2244 participants

PSMA PET/CT for Assessment of Recurrent Prostate Cancer

Study Type:: OBSERVATIONAL
Last Updated:: 2024-11-07
Start Date:: 2017-03-16
Completion:: 2027-11-30

Conditions

Prostatic Neoplasms
Prostate Cancer

Interventions

DRUG

No Results Yet

NCT02890095 | ACTIVE_NOT_RECRUITING | NA

769 participants

Persistent Organic Pollutants and Breast Cancers (POPCASE)

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2016-01-31
Completion:: 2024-06-05

Conditions

Breast Cancer

Interventions

PROCEDURE

No Results Yet

NCT02646800 | TERMINATED | PHASE4

105 participants

Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2014-03-21
Completion:: 2014-12-21

Conditions

Aspergillosis
Candidiasis

Interventions

DRUG

No Results Yet

NCT02495987 | ACTIVE_NOT_RECRUITING

52 participants

White Adipose Tissue in Pregnancy Study

Study Type:: OBSERVATIONAL
Last Updated:: 2024-11-07
Start Date:: 2015-03-31
Completion:: 2025-03-30

Conditions

ICP
GDM

No Results Yet

NCT02488850 | COMPLETED | NA

32 participants

Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2012-12-31
Completion:: 2022-04-05

Conditions

Non-small Cell Lung Cancer

Interventions

PROCEDURE
RADIATION

No Results Yet

NCT02229084 | COMPLETED | PHASE1/PHASE2

58 participants

Vaccination of High Risk Breast Cancer Patients

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2015-01-14
Completion:: 2023-01-03

Conditions

Breast Cancer
Breast Neoplasms

Interventions

BIOLOGICAL
DRUG

Results Available

NCT02086916 | COMPLETED

122 participants

Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection

Study Type:: OBSERVATIONAL
Last Updated:: 2024-11-07
Start Date:: 2011-10-31
Completion:: 2015-02-28

Conditions

Clostridium Difficile Infection

No Results Yet

NCT02004691 | COMPLETED | PHASE2/PHASE3

36 participants

Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2015-12-18
Completion:: 2021-03-15

Conditions

Sphingomyelin Lipidosis

Interventions

DRUG

Results Available

NCT01839838 | COMPLETED | PHASE1/PHASE2

40 participants

APBI Proton Feasibility and Phase II Study

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2013-04-22
Completion:: 2022-12-23

Conditions

Stage IA-IIA Breast Cancer

Interventions

RADIATION

Results Available

NCT01815983 | WITHDRAWN | NA

0 participants

Video-Assisted Laryngoscopy Education

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2013-02-28
Completion:: 2024-06-05

Conditions

Surgery

Interventions

OTHER

No Results Yet

NCT01755975 | COMPLETED | PHASE1/PHASE2

49 participants

Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2012-12-31
Completion:: 2023-10-31

Conditions

Multiple Myeloma
Non-Hodgkin's Lymphoma

Interventions

DRUG

Results Available

NCT01747577 | COMPLETED | PHASE4

68 participants

Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2012-12-04
Completion:: 2013-10-24

Conditions

Overactive Bladder
Benign Prostate Hyperplasia
Transurethral Resection of Prostate
Photoselective Vaporization Prostatectomy

Interventions

DRUG

No Results Yet

NCT01705483 | TERMINATED | PHASE1

21 participants

A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2012-08-28
Completion:: 2014-06-11

Conditions

Pharmacokinetics of ASP9853
Non-hematologic Malignancies

Interventions

DRUG

No Results Yet

NCT01682187 | COMPLETED | PHASE1

66 participants

A Dose-Escalation Study in Participants With Recurrent Malignant Glioma

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2005-12-15
Completion:: 2012-05-22

Conditions

Glioma

Interventions

DRUG

No Results Yet

NCT01529684 | COMPLETED | PHASE1

5 participants

A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body

Study Type:: INTERVENTIONAL
Last Updated:: 2024-11-07
Start Date:: 2012-03-19
Completion:: 2012-12-08

Conditions

Advanced Solid Tumors
Pharmacokinetics of 14C-OSI-906

Interventions

DRUG

No Results Yet